Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (351-360 of 357) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 357 results.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Nature|July 3, 2019
Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Nature|November 13, 2019
Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Annals of Internal Medicine|October 8, 2008
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studiesAndrew W Roddam, Naomi E Allen, Paul Appleby, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Pageof 36

Showing results (351-360 of 357) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 357 results.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Nature|July 3, 2019
Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Nature|November 13, 2019
Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Annals of Internal Medicine|October 8, 2008
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studiesAndrew W Roddam, Naomi E Allen, Paul Appleby, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Pageof 36